SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551986-19-000046
Filing Date
2019-05-10
Accepted
2019-05-10 16:32:33
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q innt331201910-q.htm 10-Q 904623
2 EXHIBIT 31.1 ex311q12019.htm EX-31.1 16108
3 EXHIBIT 31.2 ex312q12019.htm EX-31.2 16138
4 EXHIBIT 32.1 ex321q12019.htm EX-32.1 9236
5 EXHIBIT 32.2 ex322q12019.htm EX-32.2 9327
  Complete submission text file 0001551986-19-000046.txt   5496081

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT innt-20190331.xml EX-101.INS 1007579
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT innt-20190331.xsd EX-101.SCH 47099
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT innt-20190331_cal.xml EX-101.CAL 54474
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT innt-20190331_def.xml EX-101.DEF 269311
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT innt-20190331_lab.xml EX-101.LAB 640978
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT innt-20190331_pre.xml EX-101.PRE 384303
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37797 | Film No.: 19815460
SIC: 2834 Pharmaceutical Preparations